Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Inhibition of CD39 and CD73 Cell Surface Ectonucleotidases by Small Molecular Inhibitors Enhances the Mobilization of Bone Marrow Residing Stem Cells by Decreasing the Extracellular Level of Adenosine
Mateusz Adamiak, Kamila Bujko, Katarzyna Brzeźniakiewicz‐Janus, et al.
Stem Cell Reviews and Reports (2019) Vol. 15, Iss. 6, pp. 892-899
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

CD39 Identifies the CD4+ Tumor-Specific T-cell Population in Human Cancer
Kim E. Kortekaas, Saskia J. Santegoets, Gregor Sturm, et al.
Cancer Immunology Research (2020) Vol. 8, Iss. 10, pp. 1311-1321
Open Access | Times Cited: 114
The Nlrp3 inflammasome as a “rising star” in studies of normal and malignant hematopoiesis
Mariusz Z. Ratajczak, Kamila Bujko, Monika Cymer, et al.
Leukemia (2020) Vol. 34, Iss. 6, pp. 1512-1523
Open Access | Times Cited: 87
Hematopoiesis Revolves Around the Primordial Evolutional Rhythm of Purinergic Signaling and Innate Immunity – A Journey to the Developmental Roots
Mariusz Z. Ratajczak, Kamila Bujko, Katarzyna Brzeźniakiewicz‐Janus, et al.
Stem Cell Reviews and Reports (2024) Vol. 20, Iss. 3, pp. 827-838
Open Access | Times Cited: 9
CD73: a new immune checkpoint for leukemia treatment
Huan Gao, Tingting Zhang, Ke Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 – a promising target for cancer immunotherapy
Laura Schäkel, Salahuddin Mirza, Riekje Winzer, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 8, pp. e004660-e004660
Open Access | Times Cited: 21
Synthesis, Characterization, Interactions, and Immunomodulatory Function of Ectonucleotidase CD39/CD73 Inhibitor 8-Butylthioadenosine 5′-Monophosphate
Chunyang Bi, Salahuddin Mirza, Helay Baburi, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers
Mahdi Gouravani, Nastaran Khalili, Sepideh Razi, et al.
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 2, pp. 175-187
Closed Access | Times Cited: 29
Hematopoietic stem cells on the crossroad between purinergic signaling and innate immunity
Stephanie Franczak, Henning Ulrich, Mariusz Z. Ratajczak
Purinergic Signalling (2023)
Open Access | Times Cited: 9
The adenosinergic pathway in mesenchymal stem cell fate and functions
Bruna Campos Galgaro, Liziane Raquel Beckenkamp, Martha van den M. Nunnenkamp, et al.
Medicinal Research Reviews (2021) Vol. 41, Iss. 4, pp. 2316-2349
Closed Access | Times Cited: 21
Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis
Mehdi Najar, Johanne Martel‐Pelletier, Jean‐Pierre Pelletier, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 23
Innate immunity orchestrates the mobilization and homing of hematopoietic stem/progenitor cells by engaging purinergic signaling—an update
Mariusz Z. Ratajczak, Mateusz Adamiak, Kamila Bujko, et al.
Purinergic Signalling (2020) Vol. 16, Iss. 2, pp. 153-166
Open Access | Times Cited: 21
Extracellular Adenosine (eAdo) - A2B Receptor Axis Inhibits in Nlrp3 Inflammasome-dependent Manner Trafficking of Hematopoietic Stem/progenitor Cells
Arjun Thapa, Ahmed Abdelbaset‐Ismail, Vira Chumak, et al.
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 8, pp. 2893-2911
Open Access | Times Cited: 13
Synthesis and structure–activity relationships of ticlopidine derivatives and analogs as inhibitors of ectonucleotidase CD39
Chunyang Bi, Laura Schäkel, Salahuddin Mirza, et al.
Bioorganic Chemistry (2023) Vol. 135, pp. 106460-106460
Closed Access | Times Cited: 7
Mobilization of endothelial progenitor cell in patients with acute ischemic stroke
Yushuang Deng, Jian Wang, Guiqiong He, et al.
Neurological Sciences (2017) Vol. 39, Iss. 3, pp. 437-443
Closed Access | Times Cited: 23
Involvement of P2 receptors in hematopoiesis and hematopoietic disorders, and as pharmacological targets
Kelly Juliana Filippin, Kamylla Fernanda Souza de Souza, Roberto Theodoro de Araujo Júnior, et al.
Purinergic Signalling (2019) Vol. 16, Iss. 1, pp. 1-15
Open Access | Times Cited: 20
The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing—a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking
Mateusz Adamiak, Kamila Bujko, Arjun Thapa, et al.
Leukemia (2021) Vol. 36, Iss. 1, pp. 248-256
Closed Access | Times Cited: 16
The Nlrp3 inflammasome – the evolving story of its positive and negative effects on hematopoiesis
Mariusz Z. Ratajczak, Magda Kucia
Current Opinion in Hematology (2021) Vol. 28, Iss. 4, pp. 251-261
Open Access | Times Cited: 15
Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ductal adenocarcinoma
Erika Y. Faraoni, Lincoln N. Strickland, Baylee J. O’Brien, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Inflammasomes and the Maintenance of Hematopoietic Homeostasis: New Perspectives and Opportunities
Lijing Yang, Mengjia Hu, Yukai Lu, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 309-309
Open Access | Times Cited: 14
Adenosine signaling: Optimal target for gastric cancer immunotherapy
Junqing Wang, Linyong Du, Xiangjian Chen
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Extracellular Adenine Nucleotides and Adenosine Modulate the Growth and Survival of THP-1 Leukemia Cells
Kamila Puchałowicz, Maciej Tarnowski, Marta Tkacz, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4425-4425
Open Access | Times Cited: 12
Extracellular Adenosine Triphosphate (eATP) and Its Metabolite, Extracellular Adenosine (eAdo), as Opposing “Yin–Yang” Regulators of Nlrp3 Inflammasome in the Trafficking of Hematopoietic Stem/Progenitor Cells
Mariusz Z. Ratajczak, Magda Kucia
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 10
Comparison of the efficacy of hematopoietic stem cell mobilization regimens: a systematic review and network meta-analysis of preclinical studies
Chengxin Luo, Li Wang, Guixian Wu, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Novel evidence that the P2X1 purinergic receptor–Nlrp3 inflammasome axis orchestrates optimal trafficking of hematopoietic stem progenitors cells
Kamila Bujko, Mateusz Adamiak, Ahmed Abdelbaset‐Ismail, et al.
Folia Histochemica et Cytobiologica (2022) Vol. 60, Iss. 3, pp. 280-290
Open Access | Times Cited: 7
Intracoronary Delivery of Porcine Cardiac Progenitor Cells Overexpressing IGF-1 and HGF in a Pig Model of Sub-Acute Myocardial Infarction
Cristina Prat‐Vidal, Verónica Crisóstomo, Isabel Moscoso, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2571-2571
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top